These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4126098)

  • 1. Pyrimethamine in central-nervous-system leukaemia.
    Price LA
    Lancet; 1973 Jun; 1(7815):1315. PubMed ID: 4126098
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyrimethamine in central-nervous-system leukaemia.
    Ragab AH
    Lancet; 1973 May; 1(7811):1061. PubMed ID: 4122138
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Pyrimethamine in central-nervous-system leukaemia.
    Carrera Boadella A; Pla Illa RP
    Lancet; 1973 Dec; 2(7841):1330. PubMed ID: 4127678
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of CNS leukemia in childhood. An outline of current concepts.
    Pochedly C
    Clin Pediatr (Phila); 1972 Sep; 11(9):503-8. PubMed ID: 5073799
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Pyrimethamine in prophylaxis of meningeal leukaemia.
    Hamers J; van Hove W; Baele G
    Lancet; 1974 Feb; 1(7852):310-1. PubMed ID: 4130488
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe megaloblastic anemia complicating pyrimethamine therapy.
    Chute JP; Decker CF; Cotelingam J
    Ann Intern Med; 1995 Jun; 122(11):884-5. PubMed ID: 7741386
    [No Abstract]   [Full Text] [Related]  

  • 7. [Daraprim in leukemia of the central nervous system in children].
    Armata J; Wyszkowski J; Krop J
    Pol Tyg Lek; 1972 Nov; 27(48):1895-7. PubMed ID: 4645473
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics and intraventricular therapy with methotrexate via Ommaya reservoir for central nervous system leukemia (author's transl)].
    Fujimoto T; Sasaki K; Shingaki Y; Fukui M; Kitamura K
    Rinsho Ketsueki; 1980 Mar; 21(3):320-7. PubMed ID: 7411871
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxoplasmosis of the central nervous system.
    Meredith JT
    Am Fam Physician; 1987 May; 35(5):113-6. PubMed ID: 3577983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term follow up of central nervous system leukemia in children (author's transl)].
    Yokoyama T; Fujimoto T; Ito M; Furusho K; Kin H; Hasegawa A
    Rinsho Ketsueki; 1979 Mar; 20(3):246-52. PubMed ID: 439414
    [No Abstract]   [Full Text] [Related]  

  • 11. Central nervous system leukemia.
    Bergevin PR
    N Y State J Med; 1975 Feb; 75(3):367-71. PubMed ID: 1094335
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of central nervous system leukemia in acute childhood leukemia. I. Results of intrathecal single or multiple drug combination therapy (author's transl)].
    Fujimoto T; Hasegawa K; Shin H; Kishida K; Take H
    Rinsho Ketsueki; 1975 Dec; 16(12):1109-16. PubMed ID: 1243683
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of leukemic manifestations in the central nervous system].
    Styri OB
    Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2237-8. PubMed ID: 4439381
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with the treatment of central nervous system involvement in leukemia in adults].
    Sedlácková M; Cermák J; Lukásová M; Chudomel V
    Vnitr Lek; 1985 Nov; 31(11):1075-80. PubMed ID: 4072028
    [No Abstract]   [Full Text] [Related]  

  • 15. Dexamethasone. Its effectiveness in the treatment of the acute symptoms of meningeal leukemia.
    Mitus A
    Am J Dis Child; 1969 Mar; 117(3):307-12. PubMed ID: 5765148
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal outcome after combined therapy for myeloblastic leukaemia and toxoplasmosis.
    Lancet; 1973 Mar; 1(7805):727. PubMed ID: 4120530
    [No Abstract]   [Full Text] [Related]  

  • 17. Central nervous system leukemia in childhood.
    Sembiring R
    Paediatr Indones; 1977; 17(7-8):274-80. PubMed ID: 927864
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Prognosis in central nervous system leukemia.
    Sullivan MP
    Proc Natl Cancer Conf; 1972; 7():593-9. PubMed ID: 4764928
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current pharmacological treatment approaches to central nervous system leukaemia.
    Blaney SM; Balis FM; Poplack DG
    Drugs; 1991 May; 41(5):702-16. PubMed ID: 1712705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.